Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 27, 1997

View Archived Issues

Company Profile: Supratek Pharma

Bone-targeted carbonic anhydrase inhibitors from RCT

Lilly breaks ground for new Sphinx research facility

Perkin-Elmer and PerSeptive Biosystems to merge

Biologics license issued for Carticel

U.S. patent issued for CEP-2563

Phase II trials of ISIS-3521 begin

PRISM-PLUS results on tirofiban released

TNK-tPA as effective as tPA, studies show

Innothera describes agents for venous function deficiency

Data sheet for Lariam updated

Malignant melanoma indication approved for Intron A in U.K.

New treatment option for cancer pain

BioChem Pharma files first marketing application for lamivudine in hepatitis

S-15535 tested in preclinical models of anxiety and depression

Osteopatch diagnostic system enters clinical trials

Zerit receives E.U. approval

Ergo Science submits NDA for Ergoset

InSite obtains license for retinal drug delivery technology

Antioxidant properties of T-593 contribute to gastroprotection in the rat

Calcium channel antagonist AJ-3941 for treatment of stroke

Cardiovascular and antiarrhythmic activities of HNS-32

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 24, 2024.
Enhanced Cognition: Lewy body dementia phase II pumps stock
BioWorld
Investors will get more details during the International Lewy Body Dementia Conference in Amsterdam late next month, but Wall Street is already buzzing about...
Experimental mRNA gene therapy suppresses preeclampsia in mice
BioWorld MedTech
A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...
Drug duo to Repare lack in gyno cancers? Phase I shows promise
BioWorld
Wall Street wasn’t jumping up and down about Repare Therapeutics Inc.’s early data in gynecological cancers, though the findings look positive and the company has...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.